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Abstract: Transcriptome dynamics in the longissimus muscle (LM) of young Angus cattle were evaluated at 0, 60, 120, and 220 days 
from early-weaning. Bioinformatic analysis was performed using the dynamic impact approach (DIA) by means of Kyoto Encyclopedia 
of Genes and Genomes (KEGG) and Database for Annotation, Visualization and Integrated Discovery (DAVID) databases. Between 0 to 
120 days (growing phase) most of the highly-impacted pathways (eg, ascorbate and aldarate metabolism, drug metabolism, cytochrome 
P450 and Retinol metabolism) were inhibited. The phase between 120 to 220 days (finishing phase) was characterized by the most 
striking differences with 3,784 differentially expressed genes (DEGs). Analysis of those DEGs revealed that the most impacted KEGG 
canonical pathway was glycosylphosphatidylinositol (GPI)-anchor biosynthesis, which was inhibited. Furthermore, inhibition of cal-
pastatin and activation of tyrosine aminotransferase ubiquitination at 220 days promotes proteasomal degradation, while the concurrent 
activation of ribosomal proteins promotes protein synthesis. Therefore, the balance of these processes likely results in a steady-state of 
protein turnover during the finishing phase. Results underscore the importance of transcriptome dynamics in LM during growth.
Keywords: longissimus muscle, intramuscular fat, growth, nutrition
Moisá et al
254 Bioinformatics and Biology Insights 2013:7
Background
The application of microarrays for gene expression 
profiling of longissimus dorsi skeletal muscle (LM) 
of mature beef cattle is relatively new.1–3 Although 
useful data were generated from previous studies, 
they suffer from low biological replication, lack of 
a robust bioinformatics analysis, and were static in 
nature as the animals were not sampled through-
out their lifespan. Therefore, the dynamism of the 
 transcriptome of LM from weaning until harvest in 
beef cattle remains largely unknown. Such infor-
mation is valuable to identify cellular adaptations 
that may be more susceptible to particular diets 
(eg, high-starch vs. high-fiber diets) during a given 
stage of growth (eg, the growing phase vs. the fin-
ishing phase), and potentially serve as targets for 
enhancing the quality and yield grade of the carcass 
at slaughter.
In the present study, we performed a compre-
hensive analysis of the transcriptome as it relates 
to the dynamics of canonical pathways and bio-
logical functions in LM of Angus steers during a 
period when muscle mass accretion predominates, 
the growing phase (approximately 120 days from 
early weaning), and subsequently during a period 
when fat deposition is substantial, the finishing 
phase (from the end of the growing phase through to 
slaughter), using a novel bioinformatics approach, 
the dynamic impact approach (DIA).4,5 The specific 
objectives of the present study were to determine 
(1) the metabolic pathways most impacted during 
the growing and finishing phases; (2) the pathways 
that are most impacted and their extent of activa-
tion or inhibition; and (3) distinguish the key bio-
logical processes that govern the development of 
skeletal muscle tissue, including intramuscular fat 
deposition. DIA relies on the Kyoto Encyclopedia 
of Genes and Genomes (KEGG) database and the 
Database for Annotation, Visualization and Inte-
grated Discovery (DAVID). The former was used to 
determine the most impacted canonical pathways, 
while DAVID was used to determine the most rel-
evant subcategories within the 3 gene ontology 
domains (cellular component, molecular function, 
and biological processes). The InterPro database of 
DAVID was also used to identify domains and func-
tional sites within a protein with high impact in the 
analysis.
Methods
experimental animals, diets,  
and sampling
Complete details of the animal experiment have 
been reported previously.6 Briefly, fourteen purebred 
Angus steer calves (7 animals per treatment) from the 
University of Illinois, Urbana-Champaign, beef cattle 
herd were utilized to examine the effects of two dif-
ferent levels of starch in the diet. Early weaning was 
performed at 155 ± 10 days after birth. The steers were 
randomly assigned to a high-starch (5,980 kJ/kg diet 
DM) or a low-starch (4,970 kJ/kg diet DM) diet for 
120 days. At the end of the growing phase, steers on 
each group were gradually adapted to a common high-
grain finishing diet containing 6,030 kJ calculated 
net energy for gain per kg DM. All steers received 
an implant of 20 mg oestradiol benzoate and 200 mg 
progesterone (Component E-S; Vetlife Inc., West Des 
Moines, IA, USA) after the biopsy on day 60. Muscle 
biopsies were collected at 0, 60, 120, and 220 days 
relative to the start of feeding treatment diets (ie, at 
a range in age of 155 ± 10 days). The complete pro-
cedures for biopsy, RNA extraction, and microarray 
analysis have been reported previously.7,8
Microarrays and data analysis
The details of the microarray platform used and 
the hybridization procedure have been reported 
 previously.5 Data from the microarray analysis were 
normalized for dye and microarray effects (ie, Low-
ess normalization and array centering) and used for 
statistical analysis. Data were analyzed using the 
Proc MIXED procedure of SAS (SAS, SAS Inst. Inc., 
Cary, NC). Fixed effects were diet, day (0, 60, 120, 
220), and dye (Cy3, Cy5). Random effects included 
steer and microarray. Raw P values were adjusted 
using Benjamini and Hochberg’s false discovery rate 
(FDR).9 The microarray data files are deposited at 
NCBI (GSE48136).
Dynamic impact approach (DIA)
Bioinformatics analysis of microarray data was per-
formed using DIA10 and information from the freely 
available online databases KEGG and DAVID (v6.7). 
A list of protein or gene identifiers (Entrez Gene IDs) 
was uploaded all at once to extract and summarize 
functional annotations associated with groups of 
genes or with each individual gene. Details of the 
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DIA approach and its validation have been reported 
previously.5,10
The interpretation of the bioinformatics analysis 
was based on results from KEGG pathways focus-
ing on those most impacted. The impact provides an 
evaluation of the relative importance of the change 
(flux) in a pathway and/or function in response to a 
treatment and/or change in physiological state.10 The 
most impacted pathways were obtained by evaluating 
those pathways with calculated impact values above 
50% of the total impact value of the top-impacted 
pathway independently at 60 vs. 0 (early growing 
phase), 120 vs. 60 (late growing phase), and 220 vs. 
120 (finishing phase). It should be noted that this 
approach was problematic for data obtained dur-
ing the finishing phase, 220 vs. 120, because of the 
markedly high level of impact for the glycosylphos-
phatidylinositol (GPI)-anchor biosynthesis KEGG 
pathway.  Therefore, to avoid a bias, only pathways 
at 220 vs. 120 with impact values similar to those 
in other time comparisons are discussed (Table 2). 
The direction of the impact (flux) was calculated 
according to our published procedure,10 considering 
negative flux values as inhibited or downregulated 
and positive flux values as activated or upregulated. 
 Additional File 1 contains information on flux and 
impact values for each pathway, including the cut-off 
impact value above which pathways were considered 
most impacted and used for biological interpretation.
Results
There was no statistically significant effect of treat-
ment therefore the present analysis is centered on the 
DIA analysis of differentially expressed genes (DEGs) 
due to time. Results for total number of DEGs due 
to time are presented in Figure 1. The highest num-
ber (P value , 0.05; FDR , 0.01) of downregulated 
(1,799) and upregulated (1,985) DEGs was observed 
during the finishing phase (220 vs. 120). The lowest 
number (P value , 0.05; FDR , 0.01) of DEGs was 
observed at 120 vs. 60, with 744 downregulated and 
690 upregulated genes. The comparison of DEGs at 
the end of the study (day 220) relative to start of the 
study resulted in the largest number of DEGs (4,032). 
The percentage of DEGs on the microarray platform 
which belong to a given pathway, is one of the values 
used to calculate the impact.10 This is one reason the 
impact of the metabolism KEGG category follows a 
similar pattern as the total number of DEGs at each 
time comparison (Fig. 1).
Most impacted pathways
When only the growing phase was considered, Ascor-
bate and aldarate metabolism (Carbohydrate Metabo-
lism subcategory), Drug metabolism—cytochrome 
P450 (Xenobiotics Biodegradation and Metabolism 
subcategory), and Retinol metabolism  (Metabolism 
of Cofactors and Vitamins subcategory) were the 
most impacted and inhibited pathways. When only 
Time comparison
60 vs. 0 120 vs. 60 220 vs. 120 220 vs. 0
# 
D
E
G
0
500
1000
1500
2000
2500
D
ir
ec
ti
o
n
 o
f 
th
e 
im
p
ac
t/
im
p
ac
t
−200
−100
0
100
200
300
400
Activated DEG
Inhibited DEG
Flux
Impact
Figure 1. Impact and direction of the impact of the Metabolism Kegg Category, total number of Differentially expressed genes (Deg) due to time on 
experiment for each time comparison. Total number of genes = 13,153 (P value , 0.05; FDr , 0.01).
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 the finishing phase was considered (220 vs. 120), 
GPI-anchor biosynthesis (Glycan Biosynthesis and 
Metabolism subcategory), Pentose and glucuronate 
interconversions (Carbohydrate Metabolism subcat-
egory), and Sulfur metabolism (Energy Metabolism 
subcategory), in that order, were the most impacted met-
abolic pathways. The first two pathways were inhibited 
while the last one was activated (Table 2). It is impor-
tant to mention that during the finishing phase, two 
glycoproteins present in the GPI-anchor biosynthesis 
pathway, glycoprotein phospholipase D (IPR001028 
or GPLD1) and phosphatidylinositol glycan anchor 
biosynthesis, class Q (PIGQ), were markedly down-
regulated resulting in the Glycan Biosynthesis and 
Metabolism KEGG subcategory having the highest 
impact level compared with all other pathways in the 
present study (Additional File 1).
Regarding the overall KEGG Metabolism 
Category results (220 vs. 0), the Drug Metabolism-
Cytochrome P450 pathway within the Xenobiot-
ics Biodegradation and Metabolism pathway, the 
Pentose and glucuronate interconversions pathway 
within the Carbohydrate Metabolism pathway, 
and the One carbon pool by folate pathway within 
the Metabolism of cofactors and vitamins path-
way were the most impacted and inhibited. More-
over, Glycosaminoglycan biosynthesis-heparan 
sulfate pathway within the Glycan Biosynthesis 
and Metabolism pathway, and the Phenylalanine, 
tyrosine and tryptophan biosynthesis pathway within 
the Amino acid Metabolism were the most impacted 
and activated (Figs. 3 and 4).
The above results are general, meaning that they 
only provide information about the overall impact and 
the general direction of the impact (flux) of each sig-
nificant pathway in the dataset. With the aim to reach 
a better understanding about the biological relevance 
of each pathway, the present analyses are also focused 
on the significant biological processes, molecular 
functions, cellular components, and domains and 
important sites of proteins (GO-Interpro) within each 
significantly impacted pathway.
During the beginning of the growing phase, 
in the pathways where cytochromes were present 
(Metabolism of xenobiotics by cytochrome P450 
and Arachidonic Acid Metabolism), epoxide hydro-
lases (GO:0004301∼epoxide hydrolase activity) and 
Flavin-containing monooxygenase 3 (IPR002255: 
Flavin-containing monooxygenase (FMO)) were 
inhibited. Moreover, a number of cytochromes that 
belong to the Arachidonic Acid Metabolism path-
way were activated during the entire growing phase. 
Data also suggest that prostaglandin (PG) synthe-
sis (via IPR002972:Prostaglandin D synthase— 
Arachidonic Acid Metabolism) was inhibited 
during the second half of the growing phase and 
was then activated during the finishing phase. In 
addition, in the Drug metabolism—cytochrome 
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Figure 3. Results of the most impacted pathways during the growing phase and finishing phase (220 vs. 0) uncovered by the Dynamic Impact Approach 
(DIA) based on Kyoto encyclopedia of genes and genomes (Kegg) Pathways database analysis of the bovine muscle transcriptome. Columns represent 
the direction of the pathway (green color = inhibition, red color = activation). Continuous black lines show the impact of each pathway (P value , 0.05; 
FDr , 0.01).
P450 KEGG pathway during the finishing phase, 
Aldehyde oxidase 1 (IPR014313) had a strong acti-
vation (Table 3).
The Retinol metabolism pathway and Pantothen-
ate and CoA biosynthesis pathway were the highest 
impacted pathways within the subcategory Metabolism 
of Cofactors and Vitamins during the  beginning of the 
growing phase (Additional File 1). The Retinol metab-
olism had a marked inhibition of cytochrome P450 
enzymes (IPR008066:Cytochrome P450, E-class, 
group I, CYP1) and a wide variety of dehydroge-
nases (Additional File 2-Interpro and MF 60 vs. 0). 
Moisá et al
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Figure 4. Results of the most impacted pathways during the growing phase and finishing phase (220 vs. 0) uncovered by the Dynamic Impact Approach 
(DIA) based on Kyoto encyclopedia of genes and genomes (Kegg) Pathways database analysis of the bovine muscle transcriptome. Columns represent 
the direction of the pathway (green color = inhibition, red color = activation). Continuous black lines show the impact of each pathway (P value , 0.05; 
FDr , 0.01).
The overall inhibition observed for Pantothenate and 
CoA biosynthesis during the first half of the growing 
phase was associated primarily with marked down-
regulation of the pantetheine hydrolase (Vanin-1) 
(GO:0017159∼pantetheine hydrolase activity) enzyme 
(Table 3, Additional File 1).
Within the Amino acid Metabolism KEGG 
subcategory, metabolism of histidine, tyrosine and 
phenylalanine were the most impacted. Monoam-
ine oxidase B (EC:1.4.3.4 or MAOB) is an enzyme 
common to the histidine, tyrosine, and phenylala-
nine metabolic pathways which produces an evident 
inhibition of the tyrosine and phenylalanine pathway 
during the early growing phase (Additional File 1). 
During the finishing phase, the tyrosine aminotrans-
ferase (TAT) (IPR005957) enzyme was strongly 
Muscle transcriptomics during growth
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activated, determining a high impact for the Pheny-
lalanine, tyrosine, and tryptophan biosynthesis path-
way during this stage. The enzyme gamma-glutamyl 
transpeptidase (GGT) (IPR000101) is common to the 
Taurine and Hypotaurine Metabolism and Cyanoam-
ino acid Metabolism pathways, both subcategories of 
 Metabolism of others amino acids. The GGT enzyme, 
was inhibited with a high impact during the beginning 
of the growing phase (60 vs. 0) and during the finish-
ing phase (220 vs. 120). Moreover, cysteine dioxyge-
nase (CDO1) activity (GO:0017172) was increased 
during the finishing phase (Fig. 3 and Table 3).
The Glyoxylate and dicarboxylate metabolism 
pathway had inhibition during early growing phase 
due to glutamate-ammonia ligase (IPR008146: Glu-
tamine synthetase, catalytic region) and citrate syn-
thase (IPR010109:Citrate synthase, eukaryotic) 
downregulation during this period. The Glycolysis/
Gluconeogenesis pathway had the highest impact 
during the early growing phase due to inhibition of 
the enzymes phosphoenolpyruvate carboxykinase 
(PCK1) and alcohol dehydrogenase (ADH). During the 
second half of the growing phase, the bioinformatics 
analysis identified that synthesis of dihydroxyacetone 
phosphate (GO:0004807∼triose-phosphate isomerase 
activity) and the glyceraldehyde-3- phosphate meta-
bolic process (GO:0019682) were inhibited, while 
the Lactate dehydrogenase activity was upregulated. 
Moreover, L-lactate dehydrogenase (GO:0004459∼L-
lactate dehydrogenase activity, IPR011304:L-lactate 
dehydrogenase) and all glycolytic enzymes men-
tioned above were activated during the finishing 
phase. Lastly, Butanoate metabolism was in general 
inhibited in the first half of the growing phase due 
namely to downregulation of butyrate-CoA ligase 
activity (GO:0047760). This enzyme, however, was 
upregulated during the second half of the growing 
phase (Table 3).
Most recurrent pathways
The Pentose and glucuronate interconversions and 
Sulfur Metabolism pathways were the most recur-
rent pathways in the dataset. They had impact val-
ues greater than the cut-off of 50% of the maximum 
total impact at all the time comparisons analyzed. The 
impact of both pathways was greater during the finish-
ing phase, with a general inhibition of the Pentose and 
glucuronate interconversions mainly due to a strong 
downregulation of UDP-glucose 6-dehydrogenase 
(GO:0003979) and a general activation of Sulfur 
Metabolism due to a strong upregulation of the Aryl 
sulfotransferase activity (GO:0004062) (Table 3). 
A potential biological link between Pentose and 
glucuronate interconversions and Sulfur  Metabolism 
was envisaged by the upregulation of estrone sulfo-
transferase enzyme (120 vs. 60) and by the aryl sulfo-
transferase enzyme (220 vs. 120).
Flux through the Pentose and glucuronate inter-
conversions KEGG pathway also leads to the produc-
tion of an important intermediate of the TCA cycle, 
alpha-ketoglutarate (2-oxo-glutarate), which, based 
on evaluation of the pathway, would appear to have 
been reduced. UDP-glucose 6-dehydrogenase that 
produces UDP-alpha-D-glucuronate, on the other 
hand, was upregulated during the second half of the 
growing phase (120 vs. 60). In addition, Pentose and 
glucuronate interconversions in conjunction with the 
Glycosaminoglycan biosynthesis-heparan sulfate 
pathway were activated during the second half of the 
growing phase.
Also recurrent in the analysis were Ascorbate and 
aldarate metabolism and Fatty acid metabolism dur-
ing the early growing phase and, with greater impact 
at finishing phase, the KEGG pathways Steroid bio-
synthesis, Drug metabolism—cytochrome P450, 
and PPAR signaling pathway. The first three path-
ways were slightly inhibited while the last two were 
activated in the time periods where they had higher 
impact values (Additional File 1). During the early 
growing phase, Ascorbate and aldarate metabolism 
pathway downregulation was mainly due to a UDP-
glucose 6-dehydrogenase activity and Regucalcin 
(IPR008367) inhibition. The Drug metabolism—
cytochrome P450 pathway switches from inhibition 
during the growing phase, mainly due to the action of 
the xenobiotic-metabolizing enzyme FMO 3, to acti-
vation during the finishing phase due to the effect of 
Aldehyde oxidase 1 (Table 3).
The PPAR signaling pathway was inhibited during 
the early growing phase (60 vs. 0) due to the down-
regulation of phosphoenolpyruvate carboxykinase 
activity (GO:0004611), Adiponectin (bta:282865), 
uncoupling protein 1 (mitochondrial, proton car-
rier) (bta:281561 or UCP1), and solute carrier fam-
ily 27 (fatty acid transporter), member 2 (EC:6.2.1.3 
or SLC27A2). Stearoyl-CoA 9-desaturase activity 
Moisá et al
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(GO:0004768), however, had an extremely high acti-
vation during this period (data not shown).  During 
the finishing phase (220 vs. 120) PPAR targets were 
mostly activated, giving signs for activation of lipid 
transport (apolipoprotein A-I (APOA1) or apolipo-
protein A-I receptor binding (GO:0034191)) and 
apolipoprotein A-II (APOA2)), lipogenesis (stearoyl-
CoA desaturase (delta-9-desaturase) (EC:1.14.19.1 
or SCD), fatty acids transport (CD36 molecule 
(thrombospondin receptor)), β-oxidation carnitine 
palmitoyltransferase 1B (muscle) (EC:2.3.1.21 or 
CPT1B), carnitine palmitoyltransferase 1C (CPT1C), 
acyl-CoA oxidase 2, branched chain (ACOX2) and 
acetyl-CoA acyltransferase 1 (ACAA1), adipocyte 
differentiation (sorbin and SH3 domain containing 1 
(SORBS1) and fatty acid binding protein 4, adipocyte 
(FABP4) with an effect on white fat cell differentia-
tion (GO:0050872), and acylglycerol biosynthetic 
process (GO:0046463) (Tables 2 and 3).
The Steroid biosynthesis pathway was inhibited 
during the finishing phase due to a downregulation 
of cholesterol transporter activity (GO:0017127) and 
cholesterol synthesis by downregulation of emopamil 
binding proteins (IPR007905). The PPAR signal-
ing pathway had a higher impact during the finish-
ing phase as a result of upregulation of leukotriene 
biosynthetic process (GO:0019370) (ie, arachidonic 
acid), stearoyl-CoA 9-desaturase activity, glycerol 
kinase activity (GO:0004370), and acyl-CoA oxidase 
activity (GO:0003997) among others (Table 3).
The overall inhibition of Fatty acid Metabolism 
during the early growing phase was primarily due 
to a marked downregulation of enzymes involved in 
the β-oxidation process, GO:0004085∼butyryl-CoA 
dehydrogenase activity, IPR006089:Acyl-CoA dehy-
drogenase, conserved site, and GO:0004022∼alcohol 
dehydrogenase (NAD) activity (Additional File 2). 
Acyl carnitine transport activation during the begin-
ning of the growing phase is potentially associated 
with use of short-chain branched fatty acids in LM 
tissue (Additional File 2). This reaction was accom-
panied by the activation of the mitochondrial Acyl-
CoA dehydrogenase short branched chain (ACADSB) 
(Fatty acids Metabolism) and the inhibition of the 
others Acyl-CoA dehydrogenases (ACADS, ACADM, 
ACADL, ACADVL) and butyryl-CoA ligase (Butanoate 
Metabolism). Interestingly, there was a marked upreg-
ulation of acyl carnitine transport (GO:0006844∼acyl 
carnitine transport) during early growing phase. In the 
second half of the growing phase, the modest activa-
tion of the Fatty acid metabolism pathway was due to 
upregulation of the enzyme 3-hydroxyacyl-CoA dehy-
drogenase (IPR006180:3-hydroxyacyl-CoA dehy-
drogenase, conserved site) and the general activation 
of the Acyl-CoA dehydrogenases. Lastly, a number 
of NADPH-generating enzymes, specially alcohol 
dehydrogenase (GO:0004022∼alcohol dehydroge-
nase (NAD) activity) and L-glucuronate reductase 
(GO:0047939∼L-glucuronate reductase activity), 
were upregulated during the finishing phase.
Other categories
The highest-impact subcategory within Genetic Infor-
mation Processing was Translation, due to downreg-
ulation of expression of the eukaryotic translation 
initiation factor 4F complex (GO:0016281) during 
the early growing phase and a strong activation dur-
ing the finishing phase by means of the upregulation 
of 50 different ribosomal proteins (Table 1). In con-
trast, Replication and Repair was highly impacted, 
but was inhibited during the finishing phase.
Within the Environmental Information Processing 
category, the subcategory Membrane transport had the 
highest impact and was inhibited during the finishing 
phase due to the inhibition of the ABC transporters 
pathway (IPR005951) (Additional File 1). The inhib-
ited Cell communication and Cell motility were the 
most impacted Cellular Processes categories, espe-
cially during the finishing phase (Table 1).
Within the Organismal Systems category, Sen-
sory system and Development subcategories were 
the most impacted during the finishing phase. In par-
ticular, Development had a relatively low inhibition 
at the beginning of the growing phase and a slight 
activation at the second half of the growing phase, 
ending with a strong inhibition during the finishing 
phase (Additional File 3).
The subcategories of pathways related to Human 
Diseases have little to do with bovine LM and will not 
be discussed in detail. However, the results indicated 
that these pathways were strongly impacted in  general 
during the finishing phase (Additional File 3).
Discussion
The mechanism of mRNA translation is mediated by 
ribosomes and begins with the formation of a ternary 
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Table 1. Results of flux and impact uncovered by the Dynamic Impact Approach (DIA) based on Kyoto Encyclopedia of 
genes and genomes (Kegg) Pathways database analysis of the bovine muscle transcriptome for each time comparison.
category 60 vs. 0 120 vs. 60 220 vs. 120 220 vs. 0
1. Metabolism
  1.1. Carbohydrate metabolism
  1.2. energy metabolism
  1.3. Lipid metabolism
  1.4. Nucleotide metabolism
  1.5. Amino acid metabolism
  1.6. Metabolism of other amino acids
  1.7. glycan biosynthesis and metabolism
  1.8. Metabolism of cofactors and vitamins
  1.9. Metabolism of terpenoidsand polyketides
  1.10. Biosynthesis of other secondary metabolites
  1.11. Xenobiotics biodegradation and metabolism
2. Genetic information processing
  2.1. Transcription
  2.2. Translation
  2.3. Folding, sorting and degradation
  2.4. replication and repair
3. environmental information processing
  3.1. Membrane transport
  3.2. Sign transduction
  3.3. Signaling molecules and interaction
4. cellular processes
  4.1. Transport and catabolism
  4.2. Cell motility
  4.3. Cell growth and death
  4.4. Cell communication
5. Organismal systems
  5.1. Immune system
  5.2. endocrine system
  5.3. Circulatory system
  5.4. Digestive system
  5.5. excretory system
  5.6. Nervous system
  5.7. Sensory system
  5.8. Development
  5.9. environmental adaptation
notes: Flux represents the direction of each category and the corresponding subcategory (green color = inhibition, yellow color = stable, red color = 
activation, with different color intensities according to the level of upregulation or downregulation). Blue lines show the impact of each category and the 
corresponding subcategories (P value , 0.05; FDr , 0.01).
complex between amino-acylated initiator methion-
ine tRNA, GTP, and the initiation factor 2.11 In our 
study, the cellular metabolic process in which a pro-
tein is formed was extremely activated during the fin-
ishing phase, denoting signs of LM growth in steers. 
The greater number of DEGs observed in the finishing 
phase indicates that the skeletal muscle might have 
been more physiologically active in comparison with 
the growing phase (Fig. 1). This idea is supported by 
the fact that Translation was the subcategory within 
Genetic Information Processing with the highest 
impact, due to the apparent activation of the Ribosome 
pathway, ie, translation of mRNA appeared more 
robust. Under this scenario, the inhibition of ABC 
transporters that require ATP hydrolysis to translo-
cate various substrates across membranes would have 
spared energy required for translation.12,13
Carbohydrate metabolism
The finding that several pathways related to the KEGG 
subcategory Carbohydrate Metabolism had a high 
impact and were in general inhibited during the first-
half of the growing phase (60 vs. 0), reflected poten-
tially novel adaptations of LM tissue during the early 
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stages of rapid growth. For instance, the Ascorbate and 
aldarate metabolism and the Pentose and Glucuronate 
Interconversions pathways were identified as affected 
due to the fact that regucalcin and UDP-glucose 
6- dehydrogenase (GO:0003979 or UDPGDH) had a 
considerable downregulation in expression level in 
both pathways. That result highlights two biological 
mechanisms which could affect myogenesis during the 
early growing phase.  Regucalcin leads to  activation 
of proteolysis14 and the general inhibition of Pentose 
and glucuronate interconversions was mainly due to 
a strong downregulation of UDPGDH, which might 
have reduced the conversion of UDP-glucose into 
UDP-glucuronate, a nucleoside diphosphate sugar 
with a central role in glycogen biosynthesis in skele-
tal muscle.15,16  Therefore, UDPGDH  inhibition might 
have led to greater glycogen synthesis and regucalcin 
inhibition might have had a positive effect on pro-
tein synthesis during the early growing phase and the 
finishing phase. Both biological mechanisms could 
serve as signals for LM muscle growth in beef steers 
especially during the early growing phase.
The fact that the Glycolysis/Gluconeogenesis path-
way was significantly impacted during the early grow-
ing phase reflects the metabolic activity in cells within 
the LM, including myocytes and intramuscular fat. 
Within this pathway, the enzyme phosphoenolpyruvate 
carboxykinase (PCK1), inhibited at this stage, is impor-
tant for gluconeogenesis in liver and for glyceroneo-
genesis in adipose and muscle tissue17 as it catalyzes the 
conversion of oxaloacetate to phosphoenolpyruvate. 
The pathway was in general inhibited during the early 
growing phase, switching to an active state during the 
late growing and finishing phases. Therefore, from a 
biological standpoint, the later changes in PCK1 were 
likely related to the synthesis of glycerol-3-phosphate 
needed for triacylglycerol formation within the intra-
muscular adipocyte,15 a process that is expected to be 
more active during the finishing phase.
The upregulation of L-lactate dehydrogenase 
(GO:0004459∼L-lactate dehydrogenase activity) 
during the finishing phase is consistent with the 
concept that lactate is an important lipogenic sub-
strate in bovine intramuscular fat,16 and could have 
been related with greater use of rumen-derived lac-
tate for fatty acids synthesis.18 Moreover, activation 
of L-glucuronate reductase, an NADPH-generating 
enzyme during the finishing phase, was probably an 
adaptation of LM tissue (intramuscular adipose) to 
sustain greater rates of fatty acids synthesis.18
Amino acid metabolism
Gamma glutamyl transpeptidase (GGT) is an 
enzyme within the Taurine and Hypotaurine metab-
olism and Cyanoamino acid metabolism pathways 
with a significant impact during the early growing 
phase in this study. The role of GGT is key in the 
synthesis and degradation of extracellular gluta-
thione (GSH),19 LDL oxidation,20 and xenobiotic 
detoxification.21 Its activity is important for amino 
acid transport across cellular membranes.22 During 
amino acid transport across cellular membranes, 
Gamma-Glutamyl moieties of GSH are hydrolyzed 
and transferred to other amino acids, leading to the 
formation of gamma-glutamyl amino acids, which 
are then transported into the cell.23 Therefore, the 
cleavage of the gamma-glutamyl bond of extracel-
lular GSH allows cells to use this antioxidant com-
pound as a source of cysteine for increased synthesis 
of intracellular GSH.24
The recovery of cysteine, mediated by GSH 
metabolism, becomes critical for protein synthesis. In 
contrast, high levels of cysteine are relatively toxic 
in the body.23 Cysteine catabolism is tightly adjusted 
via regulation of cysteine dioxygenase (CDO1) lev-
els in the liver.25 Additionally, GSH depletion led to 
sustained activation of NF-kB (nuclear factor kappa-
light-chain-enhancer of activated B cells), which 
inhibits myogenesis.14 Our results emphasize that, on 
one hand, the activation of GSH synthesis after the 
early growing phase could have signaled greater acti-
vation of amino acid transport into cells for protein 
synthesis while, on the other hand, during the finish-
ing phase, cysteine is catabolized by CDO1 likely 
to control intracellular cysteine levels partly to pre-
vent of the occurrence of oxidative stress during a 
physiological period when intracellular fat deposition 
increases.26
Monoamine oxidase B (MAOB) is an enzyme 
common to the histidine, tyrosine, and phenylala-
nine metabolic pathways. Its inhibition during the 
early growing phase might have been associated 
with lower insulin-like stimulation of glucose trans-
port in adipocytes by means of the monoamine oxi-
dase-dependent oxidation of tyramine.41,42 Amine 
oxidation of tyramine by MAOB (IPR002938) leads 
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to the production of hydrogen peroxide (H2O2), a 
well-known insulin-like agent that enhances glucose 
transport.27 Our results revealed that during the late 
growing phase, this glucose transport blockage was 
established potentially to regulate the increase of glu-
cose influx into the cells (Additional File 2).6
Insulin-dependent TAT activation28,29 seems to 
be an important mechanism controlling amino acid 
metabolism during the early growing and the fin-
ishing phases. TAT was highly activated as its ubiq-
uitination region (IPR011715) was upregulated 
(Additional File 2). TAT contains two phosphoryla-
tion sites, including CAPK at Ser29, and a casein 
kinase II site.30 This ubiquitin-dependent degradation 
of TAT might explain why the negative regulation of 
proteasomal ubiquitin-dependent protein catabolic 
process (GO:0032435) was the biological process 
which had the highest inhibition during the finishing 
phase.
There were two mechanism which could explain 
this targeted proteasomal degradation: (a) Desmin, a 
type III intermediate filament (GO:0045098) impor-
tant in muscle cell architecture and structure,31 was 
extremely inhibited during the finishing phase; and 
(b) Calpastatin, an inhibitor of a calcium-dependent 
cysteine protease called Calpain,32 was activated dur-
ing the finishing phase (Additional File 2). Calpains 
plays a key role in post-mortem tenderization of meat 
and may be involved in muscle protein degradation 
in living tissue.33 These mechanisms were suggestive 
of signs of degradation or destabilization of the mus-
cular structure.
glycan biosynthesis and metabolism
The highly-impacted inhibition of GPI-anchor bio-
synthesis pathway in our study agrees with previous 
results.5 GPI anchor is a glycolipid that can be attached 
to the C-terminus of a protein during posttranslational 
modification.34 In adipose tissue, GPI-anchored pro-
teins bind to Caveolins by a mechanism known as 
palmitoylation.35 Caveolins are a family of integral 
membrane proteins which are the principal compo-
nents of caveolae membranes and they are involved in 
receptor-independent endocytosis.36 Caveolae, a spe-
cial type of lipid raft, are a small invagination of the 
plasma membrane and is the place were insulin recep-
tors are localized in adipocytes. Caveolae are mainly 
formed and maintained by caveolins.  Caveolins are 
synthesized as monomers and transported to Golgi 
apparatus. During their transport through secretory 
pathway, caveolins associate with lipid rafts, where 
GPI-linked proteins are preferentially located, and 
form oligomers. These oligomerized caveolins then 
form the caveolae.37
The presence of caveolins leads to the local change 
in morphology of the membrane.38 Expression of 
palmitoylated caveolins is required for the efficient 
transport of GPI-linked proteins from the Golgi com-
plex to the plasma membrane.35 Caveolins interact 
with the catalytic subunit of protein kinase A (PKA) 
and inhibit cyclic AMP (cAMP)-mediated signal 
transduction in vivo.39 When PKA-dependent phos-
phorylation is inhibited, it leads to impaired access 
of triacylglycerol lipases such as hormone-sensitive 
lipase.40 During the finishing phase, although there 
were signs that the PKA gene was being transcribed 
(Tie2 Ig-like domain 1, N-terminal (IPR018941) acti-
vation), caveolins were not expressed (Additional 
File 2). This is potentially due to a marked down-
regulation of GPI specific phospholipase (GPLD1) 
and phosphatidylinositol glycan anchor biosynthe-
sis, class Q (PIGQ) (Table 3) which contributed to 
the general inhibition of the GPI-anchor biosynthesis 
pathway.
Palmitoylated caveolins by GPI-anchor proteins 
are needed to create a blockage in the cAMP-to-
adenosine conversion associated with lipid droplet 
hydrolysis. The end result of this mechanism due to 
the inhibition of GPI-anchor proteins would therefore 
be the inhibition of lipolysis41 during the finishing 
phase. In conclusion, the general inhibition of this 
pathway during the finishing phase could have been 
associated with promoting lipid droplet accumulation 
within intramuscular fat.
Xenobiotics biodegradation  
and metabolism
Enzymes in the Drug metabolism—cytochrome P450 
pathway catalyze the oxidation of  xenobiotics.42 
 Aldehyde oxidase 1 (AOX1) was activated with a high 
impact during the finishing phase. This enzyme is 
involved in the process of detoxification of aldehydes 
by oxidizing them to produce reactive oxygen spe-
cies (ROS). When endogenous antioxidant defenses 
are inadequate to maintain ROS production in equi-
librium, the likelihood of oxidative damage to DNA, 
Muscle transcriptomics during growth
Bioinformatics and Biology Insights 2013:7 267
lipids, proteins, and other molecules  increases.43 In 
this study, data suggest that ROS production was 
countered by the upregulation of a thiol specific anti-
oxidant (IPR000866) (Additional File 2).44  Moreover, 
a previous study provided evidence that AOX1 could 
be involved in adipogenesis29 due to the fact that 
AOX1 catalyzes the oxidation of vitamin A aldehyde 
to retinoic acid which influences adipocyte differ-
entiation. Therefore it could be possible that AOX1 
plays dual roles in LM. Additional studies must be 
performed to verify these putative roles.
In the context of adipogenesis, the marked 
inhibition of cytochrome P450 enzymes 
(IPR008066:Cytochrome P450, E-class, group I, 
CYP1) could also have had an effect on the produc-
tion of all-trans retinoic acid,45 which was likely 
associated with the general inhibition of Retinol 
Metabolism during the early growing and finishing 
phases. Retinoids regulate metabolism by activating 
specific nuclear receptors like retinoic acid recep-
tor (RAR) and retinoid X receptor (RXR). RXR het-
erodimerizes with peroxisome proliferator-activated 
receptor gamma (PPARG) leading to a regulation of 
adipogenic transcriptional machinery.46
Lipid metabolism
Cytosolic epoxide hydrolases within the Arachi-
donic Acid Metabolism pathway are induced only 
by xenobiotics, which also cause peroxisome pro-
liferation.47 During the early growing phase, cyto-
chrome P450, family 2, subfamily c (EC:1.14.14.1 
or CYP2C) activity was inhibited, leading to a 
blockage in the production of epoxyeicosatrienoic 
acid (EET) from arachidonic acid by cytochrome 
P450 epoxygenases (IPR010497:Epoxide hydro-
lase, N-terminal).48  Support for an intracellular 
mechanism of action stems from the fact that EETs 
have many characteristics of long-chain fatty acids, 
therefore, they are incorporated into cellular mem-
brane phospholipids and bind to cytoplasmic FABPs 
and PPARG.49,50
During the second half of the growing phase, the 
conversion of arachidonic acid to EET was activated, 
while the soluble epoxide hydrolase (EDHX2) was 
inhibited, likely leading to EET production during this 
stage. Interestingly, during the finishing phase the data 
obtained suggest that flux through this pathway led to 
greater conversion of EET to dihydroxyeicosatrienoic 
acids (DHETs), suggesting the presence of soluble 
epoxide hydrolases and a potential probability of 
increase in the proportion of mesenchymal stem cell-
derived adipocytes.51 With the above mechanisms in 
mind, it could be speculated that EET have a role in 
adipogenesis. More studies are required, however, to 
verify this hypothesis. On other hand, the fact that 
PGs (IPR002972) were upregulated during the fin-
ishing phase (Additional File 2) suggested utilization 
of arachidonic acid via cyclooxygenases to pro-
duce PGs.52 In turn, PGs could have served as acti-
vators of PPARG, which is implicated in adipocyte 
differentiation.53
The inhibition of mitochondrial β-oxidation 
during the early growing phase was likely a result 
of lower acyl carnitine transport54,55 in place of 
the preferential channeling of long-chain fatty 
acids towards acylglycerol formation and adipo-
cyte  differentiation. The inhibition of the carnitine 
shuttle, as well as the activation of biosynthesis 
of acylglycerols, were indicative that esterifica-
tion was one of the predominant processes during 
the finishing phase. Moreover, within the Metabo-
lism of cofactors and vitamins KEGG subcategory, 
Vanin-1, present in the Pantothenate and CoA bio-
synthesis pathway, dictates the high impact for this 
pathway. Vanin-1 is a GPI-anchored pantetheinase 
which leads to the conversion of Pantetheine to 
Pantothenate.56 The 4-phosphopantetheine moi-
ety, linked via its phosphate group to the hydroxyl 
group of serine, represents an active component of 
the acyl carrier protein (ACP) (IPR003231:Acyl 
carrier protein (ACP)) which is a central com-
ponent of the fatty acid synthase reaction.42 Data 
from this study suggest that during the finishing 
phase, the phosphopantetheine attachment site of 
the ACP (IPR006162:Phosphopantetheine attach-
ment site) was activated, hence facilitating the flux 
of carbon source through lipogenesis to generate 
intramuscular fat. Within the Endocrine System 
KEGG subcategory, the PPARG Signaling Pathway 
responses observed were expected based on previ-
ous results,57,58 demonstrating that intramuscular 
fat deposition in LM increases progressively over 
time.59 These combined results explain the tempo-
ral increase in the activation of the highly-impacted 
differentiation of white fat cells (GO:0050872) and 
biosynthesis of acylglycerols (GO:0046463).
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conclusions
The bioinformatics analyses uncovered highly-
 impacted biological processes and metabolic path-
ways, some of which are associated with glycogen 
synthesis in myocytes, some with muscle growth reg-
ulation, and others with lipid droplets. These KEGG 
pathways analyzed by the DIA approach must 
be studied in more detail to aid in the discovery 
of new molecular markers for improving carcass 
characteristics.
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